Isis Pharmaceuticals, Inc. Form 10K - page 113

Grants of Plan-BasedAwards
The following table shows for the fiscal year ended December 31, 2014, certain information regarding
grants of plan-based awards to our named executive officers:
Grants of Plan-BasedAwards in Fiscal 2014
Name
Grant Date
All Other
Stock
Awards:
Number of
Shares of
Stock or
Units
(#)
All Other
Option
Awards:
Number of
Securities
Underlying
Options
(#)
Exercise or
Base Price
of Option
Awards
($/Sh)
Grant Date
Fair Value
of Stock and
Option
Awards
(1)
($)
Stanley T. Crooke. . . . . . . . . . . . . . . . . . .
1/2/14
187,500
$39.87
$3,231,294
1/15/14
31,250
$1,489,375
Elizabeth L. Hougen. . . . . . . . . . . . . . . . .
1/2/14
45,000
$39.87
$ 775,511
1/15/14
7,500
$ 357,450
B. Lynne Parshall . . . . . . . . . . . . . . . . . . .
1/2/14
82,500
$39.87
$1,421,771
1/15/14
13,750
$ 655,325
Brett Monia. . . . . . . . . . . . . . . . . . . . . . . .
1/2/14
45,000
$39.87
$ 775,511
1/15/14
7,500
$ 357,450
Richard S. Geary . . . . . . . . . . . . . . . . . . .
1/2/14
45,000
$39.87
$ 775,511
1/15/14
7,500
$ 357,450
(1) Amounts represent the aggregate expense recognized for financial statement reporting purposes in accordance with FASBTopic
ASC 718 (‘‘ASC 718’’) for stock and option awards granted to our named executive Officers. ASC 718 expense for the option awards
is based on the fair value of the awards on the date of grant using an option-pricing model. The fair value of RSUs is based on the
market price of our common stock on the date of grant. For more information, please see Note 5,
Stockholders’ Equity
, regarding
assumptions underlying valuation of equity awards.
Narrative to Summary Compensation Table andGrants of Plan-BasedAwards Table
The Compensation Committee granted merit non-statutory stock options to the executive officers on
January 2, 2014. All of these stock options were granted out of our 2011 Plan. The options have a term of seven
years and vest at the rate of 25% for the first year and then at the rate of 2.08%per month for 36 months
thereafter during the optionee’s employment.
The Compensation Committee granted RSUs to the executive officers on January 15, 2014. All of these
RSUs were granted out of our 2011 Plan. The RSUs vest at the rate of 25%per year over four years with a
vesting commencement date of January 15, 2014.
Outstanding EquityAwards at Fiscal Year-End – Executive Officers.
The following table shows for the fiscal year ended December 31, 2014, certain information regarding
outstanding equity awards at fiscal year-end for our named executive officers.
Other than the equity awards described in the table below, there were no equity incentive plan awards
outstanding for our named executive officers at December 31, 2014.
113
I...,103,104,105,106,107,108,109,110,111,112 114,115,116,117,118,119,120,121,122,123,...186
Powered by FlippingBook